logo
Where did the potato come from? Tomatoes, 9 million years ago, apparently.

Where did the potato come from? Tomatoes, 9 million years ago, apparently.

Washington Post7 days ago
They're one of the world's most important food crops and delicious roasted, mashed or fried, but the exact genetic origins of the humble potato have long been something of a mystery to scientists.
Now, researchers say the modern-day potato evolved from hybridization of the ancestors of tomato plants and another potato-like plant, known as etuberosum, in South America up to 9 million years ago. The hybridization created the petota lineage — which includes the cultivated potato seen in supermarkets around the world, as well as 107 wild potato species.
Sandra Knapp, a plant taxonomist at the Natural History Museum in London and an author of the study, said in an interview Thursday that while scientists had known potatoes, tomatoes and etuberosum were closely related, the exact relationship had been unclear as 'different parts of the genome told us different stories.'
The new research, published Thursday in the journal Cell Press, was carried out by a team of scientists in China, the United States and United Kingdom who focused on untangling this relationship.
Scientists conducted intricate analysis of 128 genomes and found that 'all members of Petota exhibit a stable mixed genomic ancestry, derived from Etuberosum and Tomato lineages.' Researchers said they believe tomato and etuberosum share a common ancestor but diverged around 14 million years ago, before hybridization between them resulted in the origin of petota around 8 to 9 million years ago.
The combination of two distinct genes in this 'hybrid speciation' event led to a key innovation — the development of tubers in petota. Tubers, the edible part of the potato, allow the plant to reproduce without seeds or pollination as well as storing water and carbohydrates, meaning petota was able to thrive in different geographic niches and diversify into a large number of species, scientists added.
Knapp said while hybridization in plants is nothing new, the resulting plants are often sterile and it had previously been thought of as an 'evolutionary dead-end.' The latest research showed that, in fact, 'hybridization is a really potent force in evolution,' she added.
Cultivated potatoes (Solanum tuberosum), along with maize, rice and wheat make up around 80 percent of human calorie intake, the researchers said, and are renowned for being cheap, versatile and packed with carbohydrates.
However, wild potatoes are difficult to sample, and the study is the 'most comprehensive collection of wild potato genomic data ever analyzed,' lead co-author Zhiyang Zhang, a genomics expert from the Agricultural Genomics Institute at Shenzhen, said in a statement.
Scientists detailed how this hybridization event led to the creation of tubers through genes known as SP6A and IT1, derived from tomato and etuberosum respectively.
The changes came at the same time as the Andes Mountains emerged between 6 and 10 million years ago, researchers said. Having a tuber to store nutrients allowed potatoes to survive harsh weather and spread throughout cold climates in the Andes and central Mexico.
While both petota and etuberosum have underground resprouting organs which allow them to reproduce without seeds, petota became more widespread than tomato or etuerosum species, as it was able to grow in areas such as grasslands, Alpine meadows and seasonally dry rainforests, the researchers added.
Now, scientists want to understand the effect of tuber-related genes on plants and how the exact 'reshuffling' of genes in this case led to tuber formation, Knapp said, adding that it also raises the prospect of creating plants that can grow food faster, are more disease resistant and environmentally friendly.
Studying the evolution of the potato also allows scientists to think about how the traits of wild species could be used on cultivated plants to boost biodiversity and mitigate the environmental impacts of agriculture, she said.
Zhang, meanwhile, said in an interview that he hoped the findings could help 'generate a new species that maybe have a harvested fruit on the ground and a tuber in the ground.' One of his fellow researchers has joked that such a new species could be called 'tomtatoes.'
Knapp suggested that the main benefit of the findings would be to build 'better potatoes instead of building cool weird things.'
'If we're going to optimize crops, what we want to do is optimize the thing we want from them and usually when you get something that does two things, those two things are not as good as the one that does the one thing better,' she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Natera Launches Fetal Focus™: A Noninvasive Prenatal Test for Inherited Conditions
Natera Launches Fetal Focus™: A Noninvasive Prenatal Test for Inherited Conditions

Yahoo

time20 minutes ago

  • Yahoo

Natera Launches Fetal Focus™: A Noninvasive Prenatal Test for Inherited Conditions

Launch supported by strong assay performance in first milestone readout of the landmark EXPAND clinical trial AUSTIN, Texas, August 07, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal test (NIPT) for inherited conditions. When a pregnant patient is identified as a carrier of a recessive single-gene condition, medical guidelines recommend partner testing in order to determine the risk for the baby to be affected by the condition1; however, in some cases the biological father is unavailable for testing. The Fetal Focus test was designed to address this unmet need. Now if a pregnant patient tests positive with Natera's Horizon™ carrier screen for one of the five most commonly tested genes, and if the father is unavailable for testing, Fetal Focus can screen the fetus directly for that gene by simply analyzing a sample of the mother's blood. Fetal Focus is validated for the analysis of five genes: CFTR (cystic fibrosis), SMN1 (spinal muscular atrophy), HBA1 and HBA2 (alpha-thalassemia), and HBB (beta-hemoglobinopathies, including sickle cell disease). The launch is supported by data from EXPAND, a large, prospective, blinded clinical trial. The study, which was initiated in 2023, has enrolled approximately 1,300 participants to date, reflecting a diverse, multi-ethnic population from leading academic medical centers and maternal fetal medicine clinics. EXPAND is designed to be the defining clinical trial in the category, with all outcomes, including both positive and negative results, confirmed by genetic truth using prenatal or postnatal diagnostic testing. In its first milestone readout (n=101) from EXPAND, the Fetal Focus test demonstrated 91% sensitivity and successfully identified 5/5 fetuses affected by homozygous variants.2,3 Homozygous cases, where the fetus inherits the same condition-causing variant from both parents, are especially challenging to detect. Fetal Focus uses Natera's proprietary LinkedSNP™ technology to improve detection of these cases across diverse populations. "Having access to a noninvasive option like Fetal Focus can provide critical information to support decision-making during pregnancy, especially in situations where partner testing isn't possible," said John Williams, M.D., chief principal investigator for EXPAND and director of reproductive genetics at Cedars-Sinai. "Fetal Focus adds another important offering within our comprehensive reproductive health portfolio – furthering our commitment to launching products that address clinical gaps in care and are supported by rigorous clinical validation," said Sheetal Parmar, M.S., CGC, senior vice president of medical affairs for women's health at Natera. "The EXPAND study has been underway for several years, and we're pleased to release this first milestone readout." References ACOG Committee Opinion #690, Mar 2017. Internal data on file. In EXPAND, the study participants and investigators are blinded to the Fetal Focus™ test results. EXpanding Prenatal Cell Free DNA Screening Across MoNogenic Disorders (EXPAND). Accessed July 2025. About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 300 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit Forward-Looking Statements All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy and performance of our tests, or of the benefits of our tests and product offerings to patients, providers and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at and View source version on Contacts Investor Relations: Mike Brophy, CFO, Natera, Inc., investor@ Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@ Sign in to access your portfolio

Elon Musk Takes on Sam Altman, This Time Over the Chessboard
Elon Musk Takes on Sam Altman, This Time Over the Chessboard

Bloomberg

time26 minutes ago

  • Bloomberg

Elon Musk Takes on Sam Altman, This Time Over the Chessboard

In the battle to see which artificial intelligence model is the best at chess, the final has come down to Elon Musk versus Sam Altman, two tech bosses who have repeatedly clashed over the future of AI. The knock-out tournament organized by Google took place this week, with teams from the US and China pitting their large language models against each other. Along with Musk's Grok 4 and Altman's OpenAI, Deepseek, Google, Anthropic and Moonshot AI also put forward their models.

NASA Is Already Prepping To Build Trump A Nuclear Reactor On The Moon
NASA Is Already Prepping To Build Trump A Nuclear Reactor On The Moon

Forbes

timean hour ago

  • Forbes

NASA Is Already Prepping To Build Trump A Nuclear Reactor On The Moon

T his week NASA administrator Sean Duffy declared the Trump Administration's intention to land a working nuclear fission reactor on the moon by the end of the decade. 'We're in a race to the moon, in a race with China to the moon,' Duffy said. Planting reactors is more effective than planting a flag in the lunar dust. Duffy referenced the idea of a 'keep-out zone' around a reactor that effectively lays claim to a desirable area, like a craters holding frozen water. Does Duffy's 5-year timetable seem too aggressive? Not particularly, when you consider that NASA and its many contractors have been relying on atomic power for a long time. Since the 1960s, NASA has powered Apollo missions, space probes and Martian landers using radioisotopic batteries that turn the heat emitted by Plutonium-238 and other decaying isotopes into electricity. The Apollo devices are still on the moon with those on Voyager and Pioneer probes were the first manmade objects to leave the solar system. But those devices only put out 100 watts or less. The nuclear fission reactors like what Duffy is talking about are far more complicated. They generate heat by splitting apart Uranium-d238, and would put out 100 kilowatts enough to power a couple dozen homes on Earth. Do we need nuclear on the moon? A decade ago, NASA decided the answer was yes. Nighttime lasts for 14 Earth days in many lunar locations, making solar panels unreliable. And you can't burn oil, coal or gas in a vacuum even if you could get it into orbit. Nasa first validated microreactor tech via the Kilopower project, then in 2022 gave $5 million grants to three consortia to perfect 40 kilowatt designs. The specifications of the Fission Surface Power Project called for a system that weighs just 6 tons, can fit into a cylinder 13 feet in diameter and 20 feet long, and can work for 10 years, self-regulated, with no maintenance or refuelling required. It's a tough remit, says Sebatian Corbisiero, the national technical director for space reactors at the Idaho National Lab, whose team selected the companies for the year-long Nasa study. 'On Earth reactors are not designed to be low mass and small. In space you need as little mass as possible, to fit on a rocket,' he says. Corbisiero does believe a lunar reactor is an important and necessary first step to developing systems that could sustain a Martian colony. As his research group found in 2023, 'Surface nuclear power is required for a sustainable lunar presence.' The three consortia Corbisiero's group selected for the 2022 contract are Lockheed Martin, with BWXT, a team that had already been working for NASA on DRACO, a $500 million demonstration spacecraft powered by a nuclear reactor. Then there's veteran reactor builder Westinghouse, partnered with Aerojet Rocketdyne, which plans to adapt its existing eVinci microreactor. The third is startup X-Energy, teamed with Maxar and Boeing. X-Energy is working on microreactor projects for Dow Chemical and Amazon, but aims to use its own nonstandardized fuel source rather than the standardized HALEU fuel (high assay low enriched uranium) that Nasa directives call for. Corbisiero is diplomatic and won't speculate on which company approach he prefers. The final system is likely to use a Stirling engine to convert fission heat into electricity and feature meltdown-proof liquid sodium circulation. Can we get one on the moon in five years? 'Yes, in my opinion it is doable,' he says. It will depend however on continued development of the rest of the Artemis flight system (the first crewed mission Artemis II is scheduled for early 2026) and whether NASA can get the money. On Earth, microreactors cost billions. According to Duffy, the Trump Administration thinks America can't afford not to plant reactors on the moon as soon as possible. China is planning its Chang'e-8 mission in 2029 to test out methods for building a lunar base with robots and 3-d printers by the mid-2030s. Duffy says both China and the U.S. want to monopolize the best lunar real estate, near the poles, where the sun always shines; 'We have ice there, we have sunlight there. We want to get there first and claim that for America.' More from Forbes Forbes How This Billionaire Family Is Succeeding Despite The Collapse Of The American Shipping Industry By Christopher Helman Forbes Why Ramaco Says It Can Beat Its Government-Backed Rival For Rare Earth Supremacy By Christopher Helman Forbes How An Unassuming Geologist Cracked The Global Fertilizer Cartel By Christopher Helman Forbes Meet The Tiny Startup Building Stargate, OpenAI's $500 Billion Data Center Moonshot By Christopher Helman

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store